Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease

Bibliographic Details
Main Author:	Umegaki, Hiroyuki
Format:	Online
Language:	English
Published:	Wiley-Blackwell 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019267/

Similar Items

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease
by: de la Monte, Suzanne M
Published: (2012)

Brain insulin resistance in Alzheimer’s disease
Published: (2012)

New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
by: Corona, C, et al.
Published: (2011)

Care for Alzheimer's Disease
by: Umegaki, Hiroyuki, et al.
Published: (2013)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
by: Yarchoan, Mark, et al.
Published: (2014)

Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
by: Beccano-Kelly, Dayne, et al.
Published: (2012)

Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics
by: Cheng, Xuan, et al.
Published: (2015)

Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
by: Han, Sun-Ho, et al.
Published: (2014)

Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease
by: Blázquez, Enrique, et al.
Published: (2014)

Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?
by: Heinecke, Jay W., et al.
Published: (2014)

AMPD1: a novel therapeutic target for reversing insulin resistance
by: Cheng, Jidong, et al.
Published: (2014)

Novel Therapeutics in Alzheimer's Disease
by: Sabbagh, Marwan, et al.
Published: (2012)

Splicing therapeutics for Alzheimer's disease
by: Wasser, Catherine R, et al.
Published: (2016)

Insulin Receptor Expression and Activity in the Brains of Nondiabetic Sporadic Alzheimer's Disease Cases
by: Ho, Lap, et al.
Published: (2012)

Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
by: Schiöth, Helgi B., et al.
Published: (2011)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
by: Vassar, Robert, et al.
Published: (2011)

Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer's Disease: A Therapeutic Target
by: Gong, Cheng-Xin, et al.
Published: (2006)

The Role of Wnt Signaling in the Development of Alzheimer's Disease: A Potential Therapeutic Target?
by: Wan, Wenbin, et al.
Published: (2014)

Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
by: Nalivaeva, Natalia N., et al.
Published: (2014)

Caspase Cleaved Tau in Alzheimer’s Disease: A Therapeutic Target Realized
by: Rohn, Troy T.
Published: (2015)

SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)

CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer’s Disease
by: Lee, Sarah, et al.
Published: (2013)

Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis
by: Bosco, Domenico, et al.
Published: (2011)

Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets
by: Pooler, Amy M, et al.
Published: (2013)

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
by: Yoon, Sang-Sun, et al.
Published: (2012)

The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease
by: MacLeod, Ruth, et al.
Published: (2015)

Therapeutic potential of mGluR5 targeting in Alzheimer's disease
by: Kumar, Anil, et al.
Published: (2015)

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
by: Pritchard, Susanne M, et al.
Published: (2011)

What is the new target inhibiting the progression of Alzheimer's disease
by: Zhang, Lin, et al.
Published: (2013)

Next generation therapeutics for Alzheimer's disease
by: Bredesen, Dale E, et al.
Published: (2013)

Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease
by: Pérez, María José, et al.
Published: (2015)

The immunology of traumatic brain injury: a prime target for Alzheimer’s disease prevention
by: Giunta, Brian, et al.
Published: (2012)

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
by: Hoekstra, Jake G, et al.
Published: (2011)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
by: Yokono, Koichi
Published: (2013)

Pharmacotherapeutic targets in Alzheimer's disease
by: Biran, Yif'at, et al.
Published: (2009)

Targeting neuroinflammation in Alzheimer’s disease
by: Bronzuoli, Maria Rosanna, et al.
Published: (2016)

New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
by: Saito, Satoshi, et al.
Published: (2014)

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
by: Cardoso, Susana, et al.
Published: (2009)

Assessment of Potential Targets for Deep Brain Stimulation in Patients With Alzheimer’s Disease
by: Sharma, Mayur, et al.
Published: (2015)

Resveratrol as a Therapeutic Agent for Alzheimer's Disease
by: Ma, Teng, et al.
Published: (2014)